ストックスクリーナーアプリを入手
4.16
3.74%
0.15
アフターアワーズ：
4.20
0.04
+0.96%
Solid Biosciences Inc (SLDB) 最新ニュース
The Manufacturers Life Insurance Company Buys New Shares in Solid Biosciences Inc. (NASDAQ:SLDB) - Defense World
Solid Biosciences stock hits 52-week low at $4.61 - Investing.com
Wedbush Initiates Coverage on Solid Biosciences (NASDAQ:SLDB) - Defense World
Solid Biosciences’ (SLDB) Buy Rating Reiterated at HC Wainwright - Defense World
Solid Biosciences (NASDAQ:SLDB) Upgraded at Wedbush - Defense World
Wedbush Initiates Coverage of Solid Biosciences (SLDB) with Outperform Recommendation - MSN
Solid Biosciences (NASDAQ:SLDB) Rating Increased to Strong-Buy at Wedbush - MarketBeat
Solid Biosciences (NASDAQ:SLDB) Coverage Initiated by Analysts at Wedbush - MarketBeat
Solid Biosciences' SWOT analysis: gene therapy stock's potential in DMD treatment - Investing.com
Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst - Yahoo Finance
Solid Biosciences (NASDAQ:SLDB) Upgraded at Citizens Jmp - Defense World
Solid Biosciences (NASDAQ:SLDB) Research Coverage Started at JMP Securities - Defense World
HC Wainwright Reiterates Buy Rating for Solid Biosciences (NASDAQ:SLDB) - MarketBeat
Solid Biosciences initiated with an Outperform at JMP Securities - MSN
Learn to Evaluate (SLDB) using the Charts - Stock Traders Daily
Solid Biosciences (NASDAQ:SLDB) Upgraded to Strong-Buy at Citizens Jmp - MarketBeat
JMP Securities Initiates Coverage of Solid Biosciences (SLDB) with Market Outperform Recommendation - MSN
Solid Biosciences stock a buy, says JMP—proprietary capsid tech adds partnership upside - Investing.com Canada
Solid Biosciences (NASDAQ:SLDB) Now Covered by Analysts at JMP Securities - MarketBeat
Point72 Asset Management L.P. Increases Position in Solid Biosciences Inc. (NASDAQ:SLDB) - MarketBeat
Solid Biosciences secures licenses for cardiac gene therapy By Investing.com - Investing.com Canada
Solid Biosciences CEO Alexander Cumbo sells $62,236 in stock By Investing.com - Investing.com Australia
Solid Biosciences CEO Alexander Cumbo sells $62,236 in stock - Investing.com India
Solid Biosciences executive sells shares worth $25,822 By Investing.com - Investing.com Nigeria
Solid Biosciences secures licenses for cardiac gene therapy - Investing.com India
Solid Biosciences' COO David Howton sells $28,396 in stock By Investing.com - Investing.com Nigeria
Solid Biosciences executive sells shares worth $25,822 - Investing.com
Solid Biosciences' COO David Howton sells $28,396 in stock - Investing.com India
Solid Biosciences Announces Collaboration with Mayo Clinic - GlobeNewswire
Solid Biosciences reports inducement grant under Nasdaq listing rule - Yahoo Finance
Solid Biosciences Lands Major Gene Therapy Deal with Mayo Clinic for Heart Disease Breakthroughs - StockTitan
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Analysts Set Solid Biosciences Inc. (NASDAQ:SLDB) Price Target at $15.14 - MarketBeat
(SLDB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Vestal Point Capital LP Boosts Stake in Solid Biosciences Inc. (NASDAQ:SLDB) - MarketBeat
Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewswire
Solid Biosciences to Present at Citi and Piper Sandler Healthcare Conferences | SLDB Stock News - StockTitan
Cantor Fitzgerald Brokers Reduce Earnings Estimates for SLDB - MarketBeat
Solid Biosciences Reports Increased Losses Amid R&D Focus - TipRanks
(SLDB) Investment Analysis - Stock Traders Daily
Litecoin Climbs 10% In Rally - Investing.com
Is Solid Biosciences (NASDAQ:SLDB) In A Good Position To Invest In Growth? - Simply Wall St
Perceptive Advisors LLC's Strategic Acquisition in Solid Bioscie - GuruFocus.com
Vestal Point Capital, LP Increases Stake in Solid Biosciences Inc. - GuruFocus.com
FY2024 Earnings Estimate for SLDB Issued By Chardan Capital - MarketBeat
Solid Biosciences to Present at the Jefferies London Healthcare Conference - GlobeNewswire
Solid Biosciences' SWOT analysis: DMD therapy stock faces pivotal moment - Investing.com India
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):